ArticleBlood2018
Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange.
Article in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach From the Writing Committee of the American Society for Apheresis: The Tenth Special Issue.Journal of clinical apheresis · 2026Guideline
- Non-PF4/heparin-binding, platelet-activating antibodies in heparin-induced thrombocytopenia.Blood · 2026Article
- Demystifying autoimmune HIT: what it is, when to test, and how to treat.Hematology. American Society of Hematology. Education Program · 2024Review
- Approaches to management of HIT in complex scenarios, including cardiac surgery.Hematology. American Society of Hematology. Education Program · 2024Review
- Challenges in the Monitoring of Therapeutic Plasma Exchange during Acute Heparin-Induced Thrombocytopenia in Adults under ECMO.TH open : companion journal to thrombosis and haemostasis · 2024Article
- Autoimmune Heparin-Induced Thrombocytopenia.Journal of clinical medicine · 2023Review
- Effectiveness and safety of therapeutic plasma exchange to modify the functionality of heparin-induced thrombocytopenia antibodies and correct profound thrombocytopenia: A case report and literature review.Journal of intensive medicine · 2023Article
- Cardiac surgery in acute heparin-induced thrombocytopenia managed with therapeutic plasma exchange and intravenous immunoglobulin.Research and practice in thrombosis and haemostasis · 2023Article
- Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).Seminars in hematology · 2022Review
- Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.The New England journal of medicine · 2021Article
- Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.Journal of clinical apheresis · 2019Article
- Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.Transfusion · 2019Article
- Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.Haematologica · 2019Article
- A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.Haematologica · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.